BioSpace News Archive

Business

John Dawson to retire from Oxford Biomedica

Oxford Biomedica plc a leading gene and cell therapy company, announces that, after more than 13 years of service, John Dawson, Chief Executive Officer, has signalled to the Board his intention to retire from the Company.

January 17, 2022
·
3 min read
Drug Development

Sensorion Updates on SENS-401 Phase 2 trial in Sudden Sensorineural Hearing Loss

Sensorion reports results from the 115-patient Phase 2 AUDIBLE-S study of SENS-401, for the treatment of sudden sensorineural hearing loss.

January 17, 2022
·
7 min read
Midatech Pharma PLC Announces Extension of Janssen collaboration re Q-Sphera

Midatech Pharma PLC is pleased to announce the extension of its R&D collaboration with Janssen Pharmaceutica NV originally announced on 21 July 2020.

January 17, 2022
·
5 min read
Angle PLC Announces Concordance of Parsortix with tissue biopsy

ANGLE plc, a world-leading liquid biopsy company, is delighted to announce the publication of breakthrough research undertaken by the world-class team at the University of Southern California Norris Cancer Center.

January 17, 2022
·
9 min read
Business

Jens Lindberg takes office as CEO of Medivir on January 24

Medivir AB announced that Jens Lindberg will assume his position as CEO on January 24, 2022.

January 17, 2022
·
2 min read
Policy

Ascletis Announces U.S. IND Approval of ASC22 (Envafolimab), a Subcutaneously Administered PD-L1 Antibody for Functional Cure of Chronic Hepatitis B

Ascletis Pharma Inc. announces the Investigational New Drug application approval by U.S. Food and Drug Administration and initiation of global development of ASC22, a first-in-class, subcutaneously administered PD-L1 antibody for functional cure of chronic hepatitis B.

January 17, 2022
·
5 min read
Drug Development

Brazil’s SENAI CIMATEC Doses First Healthy Volunteers in Phase 1 trial of HDT Bio’s RNA COVID-19 Vaccine

HDT Bio Corp., a U.S. developer of immunotherapies for oncology and infectious diseases and SENAI CIMATEC, an important Brazilian education, research, and innovation institute, have dosed the first healthy volunteers in Brazil in a Phase 1 trial of HDT Bio’s RNA COVID-19 vaccine, HDT-301.

January 17, 2022
·
4 min read
Immuron Receives AUD $306,154 R&D Tax Concession Refund

Immuron Limited is pleased to announce that under the Australian Government’s Research and Development Income Tax Concession incentive program, the Company has received a cash refund of AUD $306,154 for eligible research and development expenditure incurred during the 2021 Financial Year.

January 17, 2022
·
1 min read
Biotech Bay

Digbi Health incorporates ethnic-relevant genetic risk scores to personalize care for metabolic and mental health conditions associated with gut and obesity

Digbi Health today announced incorporating ethnic-specific risk scores for nutrition, fitness, obesity, diabetes, hypertension, mental and digestive health across its virtual care program for people living with polychronic physical and mental illness associated with inflammatory gut and weight.

January 17, 2022
·
3 min read
Business

Stallergenes Greer Strengthens Precision Medicine Approach in Allergen Immunotherapy With Imperial College London Research Collaboration

Stallergenes Greer today announced that the company has entered into a research collaboration on the discovery of biomarkers of AIT efficacy with Imperial College London, a global top ten university with a world-class reputation in science, engineering, business and medicine.

January 17, 2022
·
3 min read